A panel of experts in regulatory strategy, intellectual property, and corporate law will illustrate how regulatory preparedness directly influences valuation, due diligence, and return on investment. Attendees will leave with actionable insights into the alignment of legal, regulatory, and business considerations within the commercialization process.

Who Should Attend:

• Investors and Due Diligence Teams: To assess regulatory risk and investment opportunities
• Entrepreneurs and Innovators: To prepare for regulatory milestones that drive commercialization
• University Affiliates and Aspiring Innovators: To translate discoveries into market-ready ventures

Key Topics Include:

• Differences between device classifications and their individual regulatory requirements
• Regulatory misconceptions that affect market timelines and valuations
• The relationship between regulatory strategy, intellectual property, and business law
• How regulatory readiness informs due diligence and reduces investment risk

This event, hosted by Keiretsu Forum, is open to members, portfolio companies, and partner universities. Participants will gain a comprehensive understanding of how regulatory preparedness shapes life sciences investment success.